Trademark Overview
On Tuesday, September 30, 2025, a trademark application was filed for XQUBIX with the United States Patent and Trademark Office. The USPTO has given the XQUBIX trademark a serial number of 99420181. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Monday, March 2, 2026. This trademark is owned by XQUBIX FUTURETECH INVESTMENTS - FZCO. The XQUBIX trademark is filed in the Chemical Products, Pharmaceutical Products, and Computer & Software Services & Scientific Services categories with the following description:
Enzymes for industrial purposes; Citric acid; Tartaric acid; Glacial acetic acid; Sulfuric acid; Hydrochloric acid; Acetic acid; Adipic acid; Benzene-based acids; Alkalies; Methyl benzene; Phenol for industrial purposes; Heterocyclic compounds; Carbides; Oligopeptides for industrial purposes; Surface active compounds for general use in the industrial arts, namely, as wetting, spreading, emulsifying, dispersing and penetrating agents; Industrial chemicals; Catalysts for oxidation processes; Catalyst supports; Catalysts for use in the manufacture of industrial chemicals; Catalysts for use in the oil processing industry; Oil-separating chemicals; Chemical preparations for scientific purposes, other than for medical or veterinary use; Chemical substances for analyses in laboratories, other than for medical or veterinary purposes; Biochemical catalysts; Antioxidants for use in the manufacture of cosmetics; Antioxidants for use in the manufacture of pharmaceuticals; Vitamins for use in the m...
Pharmaceutical preparations for skin care; Medicinal preparations for stimulating hair growth; Anti-diabetic pharmaceuticals; Slimming pills; Pharmaceutical products for the treatment of cancer; Medicines for intestinal disorders; Medicines for the treatment of cardiovascular and cerebrovascular diseases; Antiallergic medicines; Sterilizing preparations; Nutritional supplements; Air purifying preparations; Diagnostic reagents for veterinary use; Bacteriological preparations for veterinary use; Anti-infective products for veterinary use; Pesticides
Research and development of new products for others; Scientific laboratory services; Research in the field of artificial intelligence; Research and development services in the field of chemistry; Chemical research and analysis; Pharmaceutical research services; Research and development services in the field of antibodies; Conducting early evaluations in the field of new pharmaceuticals; Biological research; Testing of pharmaceuticals; Material testing; Software as a service (SAAS) services in the nature of hosting cloud-based software of others; Software as a service (SAAS) services featuring software for application and database integration
